These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 34648414)
21. Meta-analysis of the relationship between XRCC3 T241M polymorphism and colorectal cancer susceptibility. Zhang LZ; Li YS; Liu HZ Genet Mol Res; 2015 Nov; 14(4):14831-9. PubMed ID: 26600544 [TBL] [Abstract][Full Text] [Related]
22. Impact of a Missense Variation (p.S150R:AGC>AGG) in the XRCC2 Gene on Susceptibility to Colorectal Cancer. Sadat-Larijani M; Derakhshani S; Keshavarz-Pakseresht B; Nasri-Nasrabadi A; Shirkavand A; Sadat-Shandiz SA; Baghbani-Arani F Clin Lab; 2018 Mar; 64(3):233-237. PubMed ID: 29739106 [TBL] [Abstract][Full Text] [Related]
23. Association between CYP1A1 2454A > G polymorphism and colorectal cancer risk: A meta-analysis. Xu L; Wei H J Cancer Res Ther; 2015; 11(4):760-4. PubMed ID: 26881514 [TBL] [Abstract][Full Text] [Related]
24. Association between XRCC3 Thr241Met polymorphism and colorectal cancer risk. Wang Z; Zhang W Tumour Biol; 2013 Jun; 34(3):1421-9. PubMed ID: 23504553 [TBL] [Abstract][Full Text] [Related]
25. Combined effect of tobacco and DNA repair genes polymorphisms of XRCC1 and XRCC2 influence high risk of head and neck squamous cell carcinoma in northeast Indian population. Choudhury JH; Choudhury B; Kundu S; Ghosh SK Med Oncol; 2014 Aug; 31(8):67. PubMed ID: 24958516 [TBL] [Abstract][Full Text] [Related]
26. E-cadherin (CDH1) gene -160C/A polymorphism and the risk of colorectal cancer: A meta-analysis involving 17,291 subjects. Ye CC; Wang J J Gene Med; 2021 Oct; 23(10):e3370. PubMed ID: 34097324 [TBL] [Abstract][Full Text] [Related]
27. Association between ERCC1 Gene Polymorphism (rs11615) and Colorectal Cancer Susceptibility: A Meta-Analysis of Medical Image Fusion and Safety Applications. Liu M; Qiu Z; Yang Q Comput Math Methods Med; 2022; 2022():9988513. PubMed ID: 36277013 [TBL] [Abstract][Full Text] [Related]
28. A role for XRCC2 gene polymorphisms in breast cancer risk and survival. Lin WY; Camp NJ; Cannon-Albright LA; Allen-Brady K; Balasubramanian S; Reed MW; Hopper JL; Apicella C; Giles GG; Southey MC; Milne RL; Arias-Pérez JI; Menéndez-Rodríguez P; Benítez J; Grundmann M; Dubrowinskaja N; Park-Simon TW; Dörk T; Garcia-Closas M; Figueroa J; Sherman M; Lissowska J; Easton DF; Dunning AM; Rajaraman P; Sigurdson AJ; Doody MM; Linet MS; Pharoah PD; Schmidt MK; Cox A J Med Genet; 2011 Jul; 48(7):477-84. PubMed ID: 21632523 [TBL] [Abstract][Full Text] [Related]
29. Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies. Liu L; Miao L; Ji G; Qiang F; Liu Z; Fan Z Mol Biol Rep; 2013 Jun; 40(6):3943-52. PubMed ID: 23271134 [TBL] [Abstract][Full Text] [Related]
30. Data on Single Nucleotide Polymorphism of DNA Repair Genes and Breast Cancer Risk from Poland. Smolarz B; Bryś M; Forma E; Zadrożny M; Bieńkiewicz J; Romanowicz H Pathol Oncol Res; 2019 Oct; 25(4):1311-1317. PubMed ID: 29209986 [TBL] [Abstract][Full Text] [Related]
32. GSTP1 Ile105Val polymorphism and colorectal cancer risk: an updated analysis. Tan Z; Feng M; Luo Y; Sun C; Fan Z; Tan Y; Fu B; Lang J Gene; 2013 Sep; 527(1):275-82. PubMed ID: 23811488 [TBL] [Abstract][Full Text] [Related]
33. Lack of an association between XRCC2 R188H polymorphisms and breast cancer: an update meta-analysis involving 35,422 subjects. Kong B; Lv ZD; Chen L; Shen RW; Jin LY; Yang ZC Int J Clin Exp Med; 2015; 8(9):15808-14. PubMed ID: 26629080 [TBL] [Abstract][Full Text] [Related]
34. An updated meta-analysis of the association between ADIPOQ rs2241766 polymorphism and colorectal cancer. Li P; Liu H; Li C; Yang B; Kong Q; Zheng W; Li B; Jia B Tumour Biol; 2014 Mar; 35(3):2491-6. PubMed ID: 24293390 [TBL] [Abstract][Full Text] [Related]
35. A PRISMA-compliant meta-analysis on association between X-ray repair cross complementing (XRCC1, XRCC2, and XRCC3) polymorphisms and oral cancer susceptibility. Mozaffari HR; Rostamnia M; Sharifi R; Safaei M; Zavattaro E; Tadakamadla SK; Imani MM; Sadeghi M; Golshah A; Moradpoor H; Rezaei F; Omidpanah N; Hatami M Gene; 2021 May; 781():145524. PubMed ID: 33631241 [TBL] [Abstract][Full Text] [Related]
36. CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis. Peng Q; Lao X; Tang W; Chen Z; Li R; Wang J; Deng Y; Li T; Qin X; Li S PLoS One; 2014; 9(2):e87925. PubMed ID: 24498403 [TBL] [Abstract][Full Text] [Related]
37. Correlation between selected XRCC2, XRCC3 and RAD51 gene polymorphisms and primary breast cancer in women in Pakistan. Qureshi Z; Mahjabeen I; Baig R; Kayani M Asian Pac J Cancer Prev; 2014; 15(23):10225-9. PubMed ID: 25556451 [TBL] [Abstract][Full Text] [Related]
38. XRCC2 Polymorphisms and Environmental Factors Predict High Risk of Colorectal Cancer. Wang L; Ma J; Yang B; Jing F; Hu Y Med Sci Monit; 2018 May; 24():2858-2863. PubMed ID: 29748531 [TBL] [Abstract][Full Text] [Related]
39. XRCC2 rs3218536 polymorphism decreases the sensitivity of colorectal cancer cells to poly(ADP-ribose) polymerase 1 inhibitor. Xu K; Song X; Chen Z; Qin C; He Y Oncol Lett; 2014 Sep; 8(3):1222-1228. PubMed ID: 25120693 [TBL] [Abstract][Full Text] [Related]
40. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis. Xie T; Wang ZG; Zhang JL; Liu H World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]